Sanduzzi Zamparelli, S.; Fucci, V.; Rea, G.; Perna, F.; Bocchino, M.; Sanduzzi Zamparelli, A.
The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome. Diagnostics 2024, 14, 642.
https://doi.org/10.3390/diagnostics14060642
AMA Style
Sanduzzi Zamparelli S, Fucci V, Rea G, Perna F, Bocchino M, Sanduzzi Zamparelli A.
The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome. Diagnostics. 2024; 14(6):642.
https://doi.org/10.3390/diagnostics14060642
Chicago/Turabian Style
Sanduzzi Zamparelli, Stefano, Vincenzo Fucci, Gaetano Rea, Francesco Perna, Marialuisa Bocchino, and Alessandro Sanduzzi Zamparelli.
2024. "The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome" Diagnostics 14, no. 6: 642.
https://doi.org/10.3390/diagnostics14060642
APA Style
Sanduzzi Zamparelli, S., Fucci, V., Rea, G., Perna, F., Bocchino, M., & Sanduzzi Zamparelli, A.
(2024). The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome. Diagnostics, 14(6), 642.
https://doi.org/10.3390/diagnostics14060642